Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Reexamination Certificate
2004-01-23
2008-09-02
Sirmons, Kevin C. (Department: 3767)
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
C604S500000, C128S898000
Reexamination Certificate
active
07419482
ABSTRACT:
A method of vascularizing cardiac tissue using an instrument through the vascular system to an entry situs located at or adjacent the cardiac tissue is provided including providing a flowable agent comprising microspheres or microparticles having a particulate size range of 1 micron to 1 mm, introducing the agent through the instrument, imparting a particle moving force through the instrument that is generated externally to cause the microspheres or microparticles to pass directly through contiguous tissue to target cardiac tissue, the particle-moving force imparting a high pressure on the agent of several thousand psi, the microspheres or microparticles passing through the contiguous tissue without any mechanical means, whereupon the microspheres or microparticles directly enter the target cardiac tissue, forming channels in the wall of the myocardium at spaced locations and in communication with the interior of the heart, and introducing the flowable agent in the channels.
REFERENCES:
patent: 1902418 (1933-03-01), Pilgrim
patent: 2398544 (1946-04-01), Lockart
patent: 2737946 (1956-03-01), Hein, Jr.
patent: 2762370 (1956-09-01), Venditty
patent: 2800903 (1957-07-01), Smoot
patent: 3815594 (1974-06-01), Doherty
patent: 3887699 (1975-06-01), Yolles
patent: 3930505 (1976-01-01), Wallach
patent: 4165739 (1979-08-01), Doherty et al.
patent: 4315742 (1982-02-01), Nash et al.
patent: 4406656 (1983-09-01), Hattler et al.
patent: 4589412 (1986-05-01), Kensey
patent: 4631052 (1986-12-01), Kensey
patent: 4637905 (1987-01-01), Gardner
patent: 4652441 (1987-03-01), Okada et al.
patent: 4658817 (1987-04-01), Hardy
patent: 4664112 (1987-05-01), Kensey et al.
patent: 4679558 (1987-07-01), Kensey et al.
patent: 4686982 (1987-08-01), Nash
patent: 4690672 (1987-09-01), Veltrup
patent: 4700705 (1987-10-01), Kensey et al.
patent: 4747406 (1988-05-01), Nash
patent: 4747821 (1988-05-01), Kensey et al.
patent: 4749376 (1988-06-01), Kensey et al.
patent: 4790813 (1988-12-01), Kensey
patent: 4795438 (1989-01-01), Kensey et al.
patent: 4839215 (1989-06-01), Starling et al.
patent: 4900303 (1990-02-01), Lemelson
patent: 4994033 (1991-02-01), Shockey et al.
patent: 5021044 (1991-06-01), Sharkawy
patent: 5037432 (1991-08-01), Molinari
patent: 5042984 (1991-08-01), Kensey et al.
patent: 5087244 (1992-02-01), Wolinsky et al.
patent: 5112305 (1992-05-01), Barath et al.
patent: 5199951 (1993-04-01), Spears
patent: 5244460 (1993-09-01), Unger et al.
patent: 5279565 (1994-01-01), Klein et al.
patent: 5288502 (1994-02-01), McGinity et al.
patent: 5415636 (1995-05-01), Forman
patent: 5415637 (1995-05-01), Khosravi
patent: 5456667 (1995-10-01), Ham et al.
patent: 5496267 (1996-03-01), Drasler et al.
patent: 5498238 (1996-03-01), Shapland et al.
patent: 5527292 (1996-06-01), Adams et al.
patent: 5591159 (1997-01-01), Taheri
patent: 5607421 (1997-03-01), Jeevanandam et al.
patent: 5655548 (1997-08-01), Nelson et al.
patent: 5674197 (1997-10-01), van Muiden et al.
patent: 5704911 (1998-01-01), Parsons
patent: 5718921 (1998-02-01), Mathiowitz et al.
patent: 5755682 (1998-05-01), Knudson et al.
patent: 5810836 (1998-09-01), Hussein et al.
patent: 5836905 (1998-11-01), Lemelson et al.
patent: 5840059 (1998-11-01), March et al.
patent: 5871469 (1999-02-01), Eggers et al.
patent: 5878751 (1999-03-01), Hussein et al.
patent: 5879713 (1999-03-01), Roth et al.
patent: 5893840 (1999-04-01), Hull et al.
patent: 5904670 (1999-05-01), Schreiner
patent: 5912017 (1999-06-01), Mathiowitz et al.
patent: 5925016 (1999-07-01), Chornenky et al.
patent: 5935119 (1999-08-01), Guy et al.
patent: 5941868 (1999-08-01), Kaplan et al.
patent: 5997525 (1999-12-01), March et al.
patent: 6080170 (2000-06-01), Nash et al.
patent: 6086582 (2000-07-01), Altman et al.
patent: 6152141 (2000-11-01), Stevens
patent: 6261585 (2001-07-01), Sefton et al.
patent: 6443949 (2002-09-01), Altman
patent: 6641553 (2003-11-01), Chee et al.
patent: 6689103 (2004-02-01), Palasis
patent: 6709427 (2004-03-01), Nash et al.
patent: 2002/0183738 (2002-12-01), Chee et al.
patent: 2003/0191449 (2003-10-01), Nash et al.
patent: 296 19 029 (1996-11-01), None
patent: 0 807 412 (1997-11-01), None
patent: 0 876 803 (1998-11-01), None
patent: 0 876 803 (1998-11-01), None
patent: WO 97/32551 (1997-09-01), None
patent: WO 98/19614 (1998-05-01), None
patent: WO 98/39038 (1998-09-01), None
patent: WO 98/49964 (1998-11-01), None
patent: WO 99/22655 (1999-05-01), None
patent: WO 99/22658 (1999-05-01), None
patent: WO 99/27985 (1999-06-01), None
patent: WO 99/33510 (1999-07-01), None
patent: WO 99/44523 (1999-09-01), None
patent: WO 99/44524 (1999-09-01), None
Arras et al., The Delivery of Angiogenic Factors to the Heart by Microsphere Therapy, Nature Biotechnology, vol. 16, 159-162, Feb. 1998.
Bonan, Raul, M.D., Local Drug Delivery for the Treatment of Thrombus and Restenosis, The Journal of Invasive Cardiology, 8:399-408, Oct. 1996.
Edelman, et al., Basic Fibroblast Growth Factor Enhances The Coupling Of Intimal Hyperplasia And Proliferation Of Vasa Vasorum In Injured Rat Arteries, J. Chin Invest, vol. 89, Feb. 1992, 465-473.
Edelman et al., Perivascular and Intravenous Administration Of Basic Fibroblast Growth Factor: Vascular And Solid Organ Deposition, Proc. Natl. Acad. Sci., USA, vol. 90, 1513-1517, Feb. 1993.
Fasol et al., Experimental Use Of A Modified Fibrin Glue To Induce Site-Directed Angiogenesis From The Aorta To the Heart, The Journal of Thoracic and Cardiovascular Surgery, vol. 107, 1432-1439, Jun. 1994.
Goldman et al., Experimental Method For Producing A Collageral Circulation To The Heart Directly Form The Left Ventricle, The Journal of Thoracic and Cardiovascular Surgery, 31:364-374, Mar. 1965.
Harada, et al., Basic Fibroblast Growth Factor Improves Myocardial Function In Chronically Ischemic Porcine Hearts, J. Chin. Invest, vol. 94, Aug. 1994, 623-630.
Kimura et al., Cellular Response In Subretinal Neovascularization Induced by bFGF-Impregnated Microspheres, IOVS, Feb. 1999, vol. 40, 524-528.
Krabatash et al., Histological Findings After Transmyocardial Laser Revascularization, The Journal of Cardiac Surgery, 11:326-331, 1996.
Lopez, et al., Basic Fibroblast Growth Factor in a Porcine Model of Chronic Myocardial Ischemia: A comparison of Angiographic, Echocardiographic and Coronary Flow Parameters. The Journal of Pharmacology and Experimental Therapeutics, vol. 282, No. 1, pp. 385-390, 1997.
Mack et al., Biologic Bypass with the Use of Andenovirus-Mediated Gene Transfer of the Complementary Deoxyribonucleic Acid for Vascular Endothelial Growth Factor 121 Improves Myocardial Perfusion and Function in the Ischemic Porcine Heart, The Journal of Thoracic and Cardiovascular Surgery, 115:168-177, Jan. 1998.
Massimo et al., Myocardial Revascularization By A New Method Of Carrying Blood Directly From The Left Ventricular Cavity Into The Coronary Circulation, J. Thorac, Surg., 34:257-264, Aug. 1957.
Mirhoseini, et al., New Concepts in Revascularization of the Myocardium, Ann. Tho. Surg., 45:415-420, Apr. 1988.
Moosdorf, et al., Transmyocardial Laser Revascularization-Morphologic Pathophysiologic and Historical Principles of Indirect Revascularization of The Heart Muscle, Z Kardiol, 86(3):147-164, Mar. 1997.
Nishi et al., Basic Fibroblast Growth Factor Impregnated Hydrogel Microspheres For Embolization of Cerebral Arteriovenous Malformations, ASAIO Journal, 1998,M405-M410.
Pelletier, et al., Angiogenesis and Growth Factor Expression in a Model of Transmyocardial Revascularization, Annuals of Thoracic Surgery, 66:12-18, 1998.
Pifarre, et al., Myocardial Revascularization by Transmyocardial Acupuncture, A Physiologic Impossibility, The Journal of Thoracic and Cardiovascular Surgery, 58:424-431, Sep. 1969.
Sanborn, et al., Abstract of Percutaneous Endocardial Gene Therapy In Vivo Gene Transfer and Expression, The Journal of the American College of Cardiology, 33:262A, Feb. 1999.
Sellke et al., Basic FGF Enhances Endothelium-Dependent Relaxation of the Collaterial Perfused Coronary Microcirculation. The American Physiological Society, 1994, pp. H1303-H1311.
Sellke et al., Therap
Evans Douglas G.
Hoganson David M.
Nash John E.
Caesar Rivise Bernstein Cohen & Pokotilow Ltd.
Kensey Nash Corporation
Sirmons Kevin C.
Witczak Catherine N
LandOfFree
Systems and methods for delivering agents into targeted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Systems and methods for delivering agents into targeted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Systems and methods for delivering agents into targeted... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3965358